Market Cap 7.39B
Revenue (ttm) 11.70B
Net Income (ttm) -443.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 53.83
Profit Margin -3.79%
Debt to Equity Ratio 0.26
Volume 8,626,164
Avg Vol 7,302,074
Day's Range N/A - N/A
Shares Out 301.49M
Stochastic %K 62%
Beta 2.34
Analysts Sell
Price Target $19.80

Company Profile

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy,...

Industry: Healthcare Plans
Sector: Healthcare
Phone: 646 403 3677
Address:
75 Varick Street, 5th Floor, New York, United States
SamuraiPlayers
SamuraiPlayers May. 21 at 10:02 PM
You miss all the insane 400%+ runners?! Make sure to keep ticker EZRA on watch ! Starting to make a move now.. I really hope the shorts get squeezed out hard. EZRA barely has 550k shares remaining to the public . We saw a mini spike earlier.. Would not be shocked at all if it runs soon. Always try to buy before the crowd šŸ’Ž Good to swing long on $RIVN $TNXP $OSCR $RKLB this month!
0 Ā· Reply
MiloRilo
MiloRilo May. 21 at 9:32 PM
$OSCR $UNH $HUM Read past the the headlines that get pasted here - i'm not sure why they posted this but on the surface this bearish read actually confirms Blackley's bullish comments at the Raymond James Conference on membership and Bertollini's Q1 2026 earnings call because we now know CMS raised fees from 2.0% → 2.5% for 2026 specifically because they expected 30% enrollment contraction. By cutting back to 1.9% for 2027, CMS is telegraphing contractions was better than feared: 1) 2026 contraction was <30% (confirmed by KFF's 21.5%) - bullish 2) 2027 enrollment will stabilize or grow from 2026 base - bullish 3) The bear case "death spiral" scenario is officially off the table per the regulator - bullish
0 Ā· Reply
MorganHoratio
MorganHoratio May. 21 at 9:23 PM
Which stocks are better buys at current levels? $NVDA at $221 $OSCR at $22 $HIMS at $24 $PLTR at $137 $NOW at $99 Great watchlist! This perfectly captures the clash between "Big Tech AI" and "High-Growth Digital Health." At current levels, we are seeing a clear split: Tech Alliance: $NVDA ($221) remains the AI king, backed by $PLTR ($137)'s software momentum and $NOW ($99)'s enterprise moat. Health Contenders: $HIMS ($24) and $OSCR ($22) offer massive growth elasticity at highly tempting entry points. Would you play it safe with the heavy-hitting tech giants, or chase the risk-reward alpha in digital health? Which one is your absolute "Best Buy" right now? Drop your ticker and reasons below!
3 Ā· Reply
MichaelNaussCMT
MichaelNaussCMT May. 21 at 8:23 PM
Added back some of what I sold at resistance as we pulled back to the AVWAP from earnings. I was going to wait for the wrong one to return as confrimation but it looks like hes gone forever. $OSCR
1 Ā· Reply
Rstinosk
Rstinosk May. 21 at 7:31 PM
$OSCR looking to start a position here under 20.
1 Ā· Reply
FibonacciTrader_
FibonacciTrader_ May. 21 at 7:13 PM
SWING ACCOUNT UPDATE -2 Big week—some massive winners and active plays heating up: $AMZN — active, eyes on follow-through $CRCL — +60% $APLD — +40% $TSLA — +50% $OSCR — +70% Stacking winners while keeping active plays under watch is paying off. Who else is riding these setups? Momentum is real—don’t blink. I often get asked why I don’t turn this into paid content, but for me, sharing stock information is just a hobby. I’m not financially struggling, so I choose to share it for free.
0 Ā· Reply
BalticTribes
BalticTribes May. 21 at 7:07 PM
$OSCR rejection
0 Ā· Reply
BuyNowUnlimited
BuyNowUnlimited May. 21 at 6:30 PM
$OSCR goddamn, is everyone waiting for 18-19 to buy again???
0 Ā· Reply
Ashton_1nvests
Ashton_1nvests May. 21 at 6:14 PM
It might actually be healthy for $OSCR to consolidate around these levels for a while. I know everyone wants stocks to go straight up, but that is usually not how sustainable moves are built. Oscar has already had a strong run, and now the market needs time to digest the story. The company is growing members, improving margins, and moving toward meaningful profitability. That is the part I care about most. If the business keeps executing while the stock goes sideways, I do not view that as a bad thing. That can actually build a stronger base for the next move higher. Not every stock needs to rip every week. Sometimes consolidation is exactly what a long-term setup needs.
0 Ā· Reply
moneyman73
moneyman73 May. 21 at 6:05 PM
$OSCR come on oscar. Join the party
0 Ā· Reply
Latest News on OSCR
Oscar Health price target raised to $19 from $15 at Baird

2026-05-07T15:42:49.000Z - 14 days ago

Oscar Health price target raised to $19 from $15 at Baird


Oscar Health price target raised to $20 from $15 at UBS

2026-05-07T13:42:53.000Z - 14 days ago

Oscar Health price target raised to $20 from $15 at UBS


Oscar Health price target raised to $21 from $18 at Barclays

2026-05-07T11:52:54.000Z - 14 days ago

Oscar Health price target raised to $21 from $18 at Barclays


Oscar Health reports Q1 EPS $2.07, consensus $1.10

2026-05-07T10:06:00.000Z - 14 days ago

Oscar Health reports Q1 EPS $2.07, consensus $1.10


Oscar Health Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 15 days ago

Oscar Health Earnings Call Transcript: Q1 2026


Oscar Health Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 15 days ago

Oscar Health Earnings release: Q1 2026


Oscar Health Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 15 days ago

Oscar Health Quarterly report: Q1 2026


Oscar Health put volume heavy and directionally bearish

2026-05-01T15:18:15.000Z - 20 days ago

Oscar Health put volume heavy and directionally bearish


Oscar Health Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 weeks ago

Oscar Health Proxy statement: Proxy filing


Oscar Health Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 4 weeks ago

Oscar Health Proxy statement: Proxy filing


Oscar Health names Siddhartha Sankaran as Chair of the Board

2026-04-21T10:50:21.000Z - 4 weeks ago

Oscar Health names Siddhartha Sankaran as Chair of the Board


Meet Lucie. A New Way to Shop for Healthcare.

Apr 20, 2026, 6:00 AM EDT - 4 weeks ago

Meet Lucie. A New Way to Shop for Healthcare.


Oscar Health upgraded to Hold from Underperform at Jefferies

2026-04-20T09:30:38.000Z - 4 weeks ago

Oscar Health upgraded to Hold from Underperform at Jefferies


Oscar Health rises 14.3%

2026-04-08T14:09:55.000Z - 6 weeks ago

Oscar Health rises 14.3%


Oscar Health CEO buys $11.9M in common stock

2026-04-07T21:01:10.000Z - 6 weeks ago

Oscar Health CEO buys $11.9M in common stock


Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back?

Feb 25, 2026, 10:00 AM EST - 3 months ago

Oscar Health Tumbles: Can This Insurtech Disruptor Bounce Back?


Oscar Health call volume above normal and directionally bullish

2026-02-24T15:25:12.000Z - 3 months ago

Oscar Health call volume above normal and directionally bullish


Oscar Health price target lowered to $15 from $17 at UBS

2026-02-11T14:01:48.000Z - 3 months ago

Oscar Health price target lowered to $15 from $17 at UBS


Oscar Health Earnings Call Transcript: Q4 2025

Feb 10, 2026, 8:00 AM EST - 3 months ago

Oscar Health Earnings Call Transcript: Q4 2025


Oscar Health Annual report: Q4 2025

Feb 10, 2026, 8:00 AM EST - 3 months ago

Oscar Health Annual report: Q4 2025


Oscar Health Earnings release: Q4 2025

Feb 10, 2026, 8:00 AM EST - 3 months ago

Oscar Health Earnings release: Q4 2025


Oscar Health Revenue Rises, Eyes Profitability This Year

Feb 10, 2026, 7:38 AM EST - 3 months ago

Oscar Health Revenue Rises, Eyes Profitability This Year


Why This Health Care Stock Has Gained 35% This Week

Nov 26, 2025, 3:55 PM EST - 6 months ago

Why This Health Care Stock Has Gained 35% This Week


OSCR Stock Review: Strong Growth Meets Attractive Valuation

Nov 25, 2025, 9:35 AM EST - 6 months ago

OSCR Stock Review: Strong Growth Meets Attractive Valuation


Oscar Health Transcript: 7th Annual Healthcare Symposium

Nov 14, 2025, 9:50 AM EST - 6 months ago

Oscar Health Transcript: 7th Annual Healthcare Symposium


Oscar Health Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 6 months ago

Oscar Health Transcript: UBS Global Healthcare Conference 2025


Oscar Health Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Oscar Health Earnings Call Transcript: Q3 2025


Oscar Health Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Oscar Health Quarterly report: Q3 2025


Oscar Health Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 7 months ago

Oscar Health Earnings release: Q3 2025


Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call

Oct 8, 2025, 6:00 AM EDT - 8 months ago

Oscar Health, Inc. 2025 Third Quarter Earnings Conference Call


Here's why the Oscar Health stock price is in a bull run

Oct 7, 2025, 11:03 AM EDT - 8 months ago

Here's why the Oscar Health stock price is in a bull run


Hy-Vee Health and Oscar Serve Up a New Era of Employer Healthcare

Aug 14, 2025, 7:00 AM EDT - 10 months ago

Hy-Vee Health and Oscar Serve Up a New Era of Employer Healthcare


Oscar Health Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 10 months ago

Oscar Health Earnings Call Transcript: Q2 2025


Oscar Health Earnings release: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 10 months ago

Oscar Health Earnings release: Q2 2025


Oscar Health Quarterly report: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 10 months ago

Oscar Health Quarterly report: Q2 2025


Oscar Health: Should You Buy OSCR Stock At $17?

Jul 3, 2025, 9:05 AM EDT - 11 months ago

Oscar Health: Should You Buy OSCR Stock At $17?


How AI helped Oscar Health cut costs and grow

May 8, 2025, 6:35 PM EDT - 1 year ago

How AI helped Oscar Health cut costs and grow


Oscar Health Earnings Call Transcript: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Earnings Call Transcript: Q1 2025


Oscar Health Quarterly report: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Quarterly report: Q1 2025


Oscar Health Earnings release: Q1 2025

May 7, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Earnings release: Q1 2025


Oscar Health Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Proxy statement: Proxy Filing


Oscar Health Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Oscar Health Proxy statement: Proxy Filing


SamuraiPlayers
SamuraiPlayers May. 21 at 10:02 PM
You miss all the insane 400%+ runners?! Make sure to keep ticker EZRA on watch ! Starting to make a move now.. I really hope the shorts get squeezed out hard. EZRA barely has 550k shares remaining to the public . We saw a mini spike earlier.. Would not be shocked at all if it runs soon. Always try to buy before the crowd šŸ’Ž Good to swing long on $RIVN $TNXP $OSCR $RKLB this month!
0 Ā· Reply
MiloRilo
MiloRilo May. 21 at 9:32 PM
$OSCR $UNH $HUM Read past the the headlines that get pasted here - i'm not sure why they posted this but on the surface this bearish read actually confirms Blackley's bullish comments at the Raymond James Conference on membership and Bertollini's Q1 2026 earnings call because we now know CMS raised fees from 2.0% → 2.5% for 2026 specifically because they expected 30% enrollment contraction. By cutting back to 1.9% for 2027, CMS is telegraphing contractions was better than feared: 1) 2026 contraction was <30% (confirmed by KFF's 21.5%) - bullish 2) 2027 enrollment will stabilize or grow from 2026 base - bullish 3) The bear case "death spiral" scenario is officially off the table per the regulator - bullish
0 Ā· Reply
MorganHoratio
MorganHoratio May. 21 at 9:23 PM
Which stocks are better buys at current levels? $NVDA at $221 $OSCR at $22 $HIMS at $24 $PLTR at $137 $NOW at $99 Great watchlist! This perfectly captures the clash between "Big Tech AI" and "High-Growth Digital Health." At current levels, we are seeing a clear split: Tech Alliance: $NVDA ($221) remains the AI king, backed by $PLTR ($137)'s software momentum and $NOW ($99)'s enterprise moat. Health Contenders: $HIMS ($24) and $OSCR ($22) offer massive growth elasticity at highly tempting entry points. Would you play it safe with the heavy-hitting tech giants, or chase the risk-reward alpha in digital health? Which one is your absolute "Best Buy" right now? Drop your ticker and reasons below!
3 Ā· Reply
MichaelNaussCMT
MichaelNaussCMT May. 21 at 8:23 PM
Added back some of what I sold at resistance as we pulled back to the AVWAP from earnings. I was going to wait for the wrong one to return as confrimation but it looks like hes gone forever. $OSCR
1 Ā· Reply
Rstinosk
Rstinosk May. 21 at 7:31 PM
$OSCR looking to start a position here under 20.
1 Ā· Reply
FibonacciTrader_
FibonacciTrader_ May. 21 at 7:13 PM
SWING ACCOUNT UPDATE -2 Big week—some massive winners and active plays heating up: $AMZN — active, eyes on follow-through $CRCL — +60% $APLD — +40% $TSLA — +50% $OSCR — +70% Stacking winners while keeping active plays under watch is paying off. Who else is riding these setups? Momentum is real—don’t blink. I often get asked why I don’t turn this into paid content, but for me, sharing stock information is just a hobby. I’m not financially struggling, so I choose to share it for free.
0 Ā· Reply
BalticTribes
BalticTribes May. 21 at 7:07 PM
$OSCR rejection
0 Ā· Reply
BuyNowUnlimited
BuyNowUnlimited May. 21 at 6:30 PM
$OSCR goddamn, is everyone waiting for 18-19 to buy again???
0 Ā· Reply
Ashton_1nvests
Ashton_1nvests May. 21 at 6:14 PM
It might actually be healthy for $OSCR to consolidate around these levels for a while. I know everyone wants stocks to go straight up, but that is usually not how sustainable moves are built. Oscar has already had a strong run, and now the market needs time to digest the story. The company is growing members, improving margins, and moving toward meaningful profitability. That is the part I care about most. If the business keeps executing while the stock goes sideways, I do not view that as a bad thing. That can actually build a stronger base for the next move higher. Not every stock needs to rip every week. Sometimes consolidation is exactly what a long-term setup needs.
0 Ā· Reply
moneyman73
moneyman73 May. 21 at 6:05 PM
$OSCR come on oscar. Join the party
0 Ā· Reply
Stocktwits23
Stocktwits23 May. 21 at 5:45 PM
$OSCR so you are going to take a 50% ST tax gain to then buy it back? seems like a shitty way to compound your money
0 Ā· Reply
MorganHoratio
MorganHoratio May. 21 at 4:46 PM
Our team has compiled a list of the best companies in various industries: Health 1. $OSCR 2. $LLY 3. $UNH Which other companies do you think have not been included? This list completely anchors healthcare’s elite growth and defensive moats! $OSCR (crushing its Q1 with an 84% EPS blowout), $LLY (the reigning pharma king, raising guidance on a 56% Q1 revenue spike), and legacy titan $UNH make a stellar institutional trio. However, missing next-gen innovation and GLP-1 alternatives leaves a massive gap. Where is $LFMD (LifeMD), the explosive telehealth disruptor capturing the affordable weight-loss boom? And don't overlook $CCLD, fresh off its Nasdaq Analyst Day scaling as an AI-first healthcare infrastructure engine. Time to weigh in! In this polarized healthcare tape, are you sticking with high-premium giants like $LLY, or hunting for explosive, high-beta digital health dark horses like $OSCR and $LFMD? Drop your favorite tickers below! šŸ‘‡
0 Ā· Reply
DookieMachine
DookieMachine May. 21 at 3:29 PM
$OSCR yes it's called being held accountable for retarded positions that you take🤔🤔🤔 3 month timeframe is laughable, you are a child and a moron
0 Ā· Reply
BalticTribes
BalticTribes May. 21 at 3:08 PM
$OSCR not yet
0 Ā· Reply
FromPenniesTOmillions
FromPenniesTOmillions May. 21 at 2:04 PM
$OSCR enjoy the pull back… opportunity to buy
0 Ā· Reply
Ohad06
Ohad06 May. 21 at 1:37 PM
$OSCR going to fully close my position at 29.50$ for 156% ROI Then going to keep monitoring to buy all the shares back at around 20ish. Although the stock looks amazing, still needs to take profit and wait for the next leg up. I definitely believe it’ll be 45$ by next year, just needs to visit those 20s level before doing so. What it has done is nothing short of fantastic, but it is also not healthy. ENJOYING THE RIDE
0 Ā· Reply
iEdmund
iEdmund May. 21 at 11:35 AM
$OSCR $26 today
1 Ā· Reply
pocketmoney
pocketmoney May. 21 at 12:12 AM
$OSCR $UNH $HUM 🧐
1 Ā· Reply
MorganChase
MorganChase May. 20 at 11:37 PM
$OSCR šŸŽšŸŽšŸŽšŸŽ THIS IS THE gift to everyone who wanted to get in , this is the breather and the small pull back before the run up to $30ļæ¼
1 Ā· Reply
Leviathan__
Leviathan__ May. 20 at 11:32 PM
$OSCR Finally some profit taking
0 Ā· Reply
freedomtrader6
freedomtrader6 May. 20 at 10:19 PM
Watching $OSCR right now, and honestly, I’m a bit blown away—analysts are projecting nearly $30B in revenue and only $3.00 EPS by 2030. But my friend thinks they can hit $3.00 this year. Looking at the charts myself, I actually find that pretty believable. This makes it feel like analysts are way off… every time I see something like this, I can’t help but marvel at how the market always has its own rhythm. Anyone else watching this? With a gap like this, do you see it as a chance to get in early, or would you hang back and wait? I’d really love to hear your immediate thoughts.
1 Ā· Reply
RonnieVTrades
RonnieVTrades May. 20 at 9:35 PM
Stocks don't go straight up forever... $OSCR has been on an absolute tear. If we end the week here then we have a false breakout of the two year base. I'll be adding aggressively if we pullback to these levels.
1 Ā· Reply